Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -112.90% |
| Q3 2025 | 2364.06% |
| Q2 2025 | 108.23% |
| Q1 2025 | -376.20% |
| Q4 2024 | -43.28% |
| Q3 2024 | 504.51% |
| Q2 2024 | 93.68% |
| Q1 2024 | -36.04% |
| Q4 2023 | 42.07% |
| Q3 2023 | -12.36% |
| Q2 2023 | 15.38% |
| Q1 2023 | -25.63% |
| Q4 2022 | 8.42% |
| Q3 2022 | -43.94% |
| Q2 2022 | 3.79% |
| Q1 2022 | 0.77% |
| Q4 2021 | 33.41% |
| Q3 2021 | -31.05% |
| Q2 2021 | 16.17% |
| Q1 2021 | -208.87% |
| Q4 2020 | 236.41% |
| Q3 2020 | -9.21% |
| Q2 2020 | 12.83% |
| Q1 2020 | -32.30% |
| Q4 2019 | -52.08% |
| Q3 2019 | -34.84% |
| Q2 2019 | -10.05% |
| Q1 2019 | 18.08% |
| Q4 2018 | -34.24% |
| Q3 2018 | -7.94% |
| Q2 2018 | -33.83% |
| Q1 2018 | -47.66% |
| Q4 2017 | -39.46% |
| Q3 2017 | 3.13% |
| Q2 2017 | -36.44% |
| Q1 2017 | -28.76% |
| Q4 2016 | -0.48% |
| Q3 2016 | -0.63% |
| Q2 2016 | 0.00% |
| Q1 2016 | 8.09% |